INFLUVAC TETRA

BGP Pharma ULC🇨🇦 Health Canada

Approval Id: ad384331a74ee255
Drug Approval Canada Name: INFLUVAC TETRA
Product Name: INFLUVAC TETRA
Status: Marketed
Status Date: 2019-10-17
Original Market Date: 2019-10-17
Din: 02484854
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intramuscular , Subcutaneous
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Atc Name: j 07 bb 02
Aig Number: 0455410003
Company Name: BGP Pharma ULC
Company Address: 85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6

HAEMAGGLUTININ-STRAIN A (H1N1)

15 MCG / 0.5 ML

HAEMAGGLUTININ-STRAIN B (YAMAGATA)

15 MCG / 0.5 ML

HAEMAGGLUTININ-STRAIN A (H3N2)

15 MCG / 0.5 ML

HAEMAGGLUTININ-STRAIN B (VICTORIA)

15 MCG / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ad384331a74ee255

Type

Standard